According to the statistics, China's finished dosage export growth accelerated in the first three quarters of 2016. Domestic dosage of general trade exports reached 12.9 billion US dollars, which was 3.1% contrarian growth and accounted for 55% of total chemical exports, the first time higher than foreign-funded enterprises. Moreover, the exports to US market reached 230 million US dollars, which was an increase of 57%. It is obvious that the pace of domestic pharmaceutical companies to plan for the global industry chain layout has been significantly accelerated.
As an important part of CPhI China, the dosage zone is dedicated solely to Finished Dosage Formulation (FDF). FDF China will bring every aspect of the finished dosage supply chain together in one global location, from Big Pharma to in/out-licensing specialists, end product distributors, and end-user agents.
FDF China attracts the participation of many outstanding Chinese dosage exporting enterprises and will showcase high quality products which meet the international standard. The show will enable Chinese enterprises to speed up the internationalization of Western drugs and set up a great platform to display, exchange and trade in the international market.
- Chemical Drugs
- Health Care Products
- Chinese Traditional Patent Medicine
- Chinese Herbal Medicine
- Biological Products
- CRO & CMO
Other Co-located shows
*Click on the co-located logos to find out more.